The team trialed the test on 121 patients from Japan and 252 from Australia with varying levels of health, ranging from healthy to mild cognitive impairments or Alzheimer’s disease.

Rates of diagnosis and treatment are low, so there is need for diagnostic tests and biomarkers for classification and ...

A blood test that looks for biomarkers tied to Alzheimer’s disease could be the screening tool needed to identify patients earlier and get them into critical trials. In a study published Jan. 31 ...

This is the story of Alzheimer's. Dramatic ups and downs have been typical, with about 200 failed attempts to find a treatment. Drugmakers are seeking to escape a maze, trying one approach ...

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold under the same brand name Kisunla. The Alzheimer's Association ...

The study included 2,469 participants from France, Japan and Finland who ... Study co-author Jenni Lehtisalo, a research fellow at the Finnish Institute for Health and Welfare, said the main takeaway ...

A new Alzheimer's drug is offering hope for the millions of dementia sufferers among Japan's rapidly aging population. While it is yet to be approved in Japan, regulators in the United States have ...

A RESEARCH institute is to be set up in Edinburgh involving Japanese and Scottish scientists, whose work could benefit people suffering from Alzheimer's Disease.

A Japanese functional foods and cosmetics maker, in collaboration with researchers at a top Tokyo university, has published a study that reveals brown rice is effective in combating Alzheimer’s ...